New diabetes clinical trial: Empagliflozin Adjunctive Therapy in Bipolar Depression
Published on: 2026-03-16T04:00:00Z
Conditions: Bipolar Disorder; Bipolar Depression; Insulin Resistance
Interventions: Drug: Empagliflozin (EMPA)
Sponsors: University of Sao Paulo; Medical school of the University of São Paulo (FMUSP)
Not yet recruiting
https://ift.tt/k4AxjYq
Conditions: Bipolar Disorder; Bipolar Depression; Insulin Resistance
Interventions: Drug: Empagliflozin (EMPA)
Sponsors: University of Sao Paulo; Medical school of the University of São Paulo (FMUSP)
Not yet recruiting
https://ift.tt/k4AxjYq
Comments
Post a Comment